Email ID
Password
Scrip   
CHMP endorses Merck & Co fertility drug Elonva
24 November 2009
Katie McQue

The CHMP has recommended that Merck & Co's Elonva (corifollitropin alfa injection) be approved in the EU for controlled ovarian stimulation (COS) in combination with a gonadotropin-releasing hormone (GnRH) antagonist for the development of multiple follicles in women participating in assisted reproductive...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36